From The Editor
-
No Surprise: Patient Recruitment Still Sucks
2/14/2024
Patient recruitment expert Ross Jackson talks about why this part of the clinical trials ecosystem is still a problem and offers up some solutions, specifically around digital/social media outreach.
-
A Tribe Called SOS
2/5/2024
A first-hand account of a first-time industry conference. Dan Schell, chief editor of Clinical Leader, talks about his impressions of the Save Our Sites (SOS) conference that happened in Tucson, AZ on Feb. 2, 2024.
-
It’s Hard To Predict AI’s Real Value To Clinical Trials
2/1/2024
Sunny Kumar, a partner at GSR Ventures, plans to talk about AI and ML use in clinical trials during the SCOPE Summit panel, “The Future of Clinical Trial Tech: Perspectives from Different Investors.”
-
The Impact Of Protocol Design On An IRT System
1/31/2024
DTP and home treatment studies can get expensive — and be a hassle to patients — if the IRT element isn’t well planned for during trial design. In their SCOPE Summit presentation, Irina Grishina and Kelsey Kern of CSL Behring plan to share their personal anecdotes and lessons learned from both types of trials as they pertain to IRT.
-
What Is Clinical Trial Tokenization?
1/30/2024
Tokenization in clinical trials is still a new concept to many sponsors — and their patients who are volunteering for the studies. At his SCOPE Summit presentation, Tom Dougherty of Pfizer will explain this concept and discuss what trials are a fit.
-
A Closer Look At How RBQM Has Evolved In Recent Years
1/29/2024
Mary Arnould, senior director, program management/RBM lead, Clinical Science Operations at Astellas, talks about her SCOPE Summit 2024 presentation called “COVID-19 Pandemic Impact on Risk-Based Quality Management.”
-
Founders & Innovators To Share Clinical Trial Tech Insights
1/24/2024
Jodi Akin, founder of Hawthorne Effect, discusses some of the topics she will cover on the SCOPE Summit panel titled, “Overcoming Hurdles to Fundraising, Pilots, and Scaling” as part of the colocated Clinical Trial Tech: Venture, Innovation & Partnering event.
-
A Closer Look At Precision Medicine Clinical Trials
1/9/2024
As Sumitomo Pharma America (SMPA) starts to focus more on precision medicine, the sponsor is encountering a new set of challenges when it comes to running clinical trials.
-
How Re-educating PIs Can Improve Clinical Trial Diversity
12/14/2023
Usually, discussions around ways to improve diversity in clinical trials focus on changing traditional protocol-design processes, finding and tapping into larger pools of diverse patients, educating patients on the value of clinical trials — that type of stuff. You don't normally hear people talking about re-educating physicians as a solution.
-
Can Data Help Improve Diversity In Clinical Trials?
12/7/2023
Denise Bronner Ph.D., director of diversity, equity, and inclusion in clinical trials at Johnson & Johnson Innovative Medicine (JJIM) talks about some of the types of datasets that can be leveraged to improve diversity in clinical trials.